Brief: Abbott Announces Its Intention To Separate Its Global Nutrition Business Into An Independent, Publicly Traded Company
21/10/2026 12:32
BRIEF-Abbott Announces Its Intention To Separate Its Global Nutrition Business Into An Independent, Publicly Traded Company Oct 21 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT ANNOUNCES ITS INTENTION TO SEPARATE ITS GLOBAL NUTRITION BUSINESS INTO AN INDEPENDENT, PUBLICLY TRADED COMPANY
ABBOTT - SEPARATION EXPECTED TO BE COMPLETED BY END OF 2027
ABBOTT - TO SEPARATE NUTRITION BUSINESS VIA TAX-FREE DISTRIBUTION TO SHAREHOLDERS
ABBOTT - EXPECTS ONE-TIME CHARGES RELATED TO DEAL BEFORE SEPARATION
ABBOTT - COMBINED DIVIDEND TO EQUAL ABBOTT'S DIVIDEND AT TIME OF SEPARATION
ABBOTT: PLANNED SEPARATION WILL NOT IMPACT ABBOTT'S GUIDANCE FOR 2026 OR GUIDANCE FOR 2027 THAT ABBOTT PLANS TO PROVIDE IN JANUARY
Source text: ID:nPn8nTh50a
Further company coverage: ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement